The protective effects to the function of kidney and long by clearing of cytokines in patients with open-heart surgery

National Medical Journal of China

Volumn 85, Issue 45, 2005, Pages 3194-3198

  Zhang, Guo Hua ^a   Hou, Fan Fan ^a   Wang, Wu Jun ^a   Zhang, Xun ^a   Wu, Hua ^a   Liu, Zhi Qiang ^a   Tao, Hui Qin ^a  

^a FIRST MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Adsorption; Cytokines; Extracorporeal circulation; Kidney failure; Respiratory function tests

Indexed keywords

C REACTIVE PROTEIN; CELLULOSE TRIACETATE; CREATININE; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 13 RECEPTOR ALPHA1; INTERLEUKIN 6; INTERLEUKIN 8; N ACETYL BETA GLUCOSAMINIDASE; NITRILE; TUMOR NECROSIS FACTOR ALPHA;

ADSORPTION; ADULT; AIRWAY PRESSURE; ARTICLE; ARTIFICIAL VENTILATION; BLOOD ANALYSIS; BLOOD SAMPLING; BODY TEMPERATURE MEASUREMENT; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; CREATININE URINE LEVEL; EXTRACORPOREAL CIRCULATION; FEMALE; HEART RATE; HEART VALVE REPLACEMENT; HEMOFILTRATION; HUMAN; KIDNEY FUNCTION TEST; LEUKOCYTE COUNT; LUNG FUNCTION TEST; MALE; OPEN HEART SURGERY; PEAK EXPIRATORY FLOW; PROTEIN BLOOD LEVEL; PROTEIN ISOLATION; PROTEIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL; RENAL PROTECTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; URINARY EXCRETION;

ADSORPTION; ADULT; C-REACTIVE PROTEIN; CARDIAC SURGICAL PROCEDURES; CYTOKINES; EXTRACORPOREAL CIRCULATION; FEMALE; HEART VALVE DISEASES; HEMOFILTRATION; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; POLYPROPYLENES; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 31744448830     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Steinberg JB, Kapelanski DP, Olson JD. Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg, 1993, 106:1008-1016.
2. Gianetti J, Del Sarto P, Bevilacqua S, et al. Supplemental nitric oxide and its effect on myocardial injury and function in patients undergoing cardiac surgery with extracorporeal circulation. J Thorac Cardiovasc Surg, 2004, 127:44-50.
3. Holmes JH 4th, Connolly NC, Paull DL, et al. Magnitude of the inflammatory response to cardiopulmonary bypass and its relation to adverse clinical outcomes. Inflamm Res, 2002, 51:579-586.
4. van Bommel EF, Hesse CJ, Jutte NH, et al. Cytokine kinetics (TNF-alpha, IL-1 beta, IL-6) during continuous hemofiltration: a laboratory and clinical study. Contrib Nephrol, 1995, 16:62-75.
5. Uchino S, Bellomo R, Goldsmith D, et al. Cytokine removal with a large pore cellulose triacetate filter: an ex vivo study. Int J Artif Organs, 2002, 25:27-32.
6. Naik SK, Knigt A, Elliott MJ. A successful modification of ultrafiltration for cardiopulmonary bypass in children. Perfusion, 1991, 117:496-505.
7. Asimakopoulos C, Smith PLC, Ratnatunga CR, et al. Lung Injury and acute respiratory distress syndrome after cardiopulmonary bypass. Ann Thorac Surg, 1999, 68:1107-1115.
8. Wan S, LeClerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest, 1997, 112:676-692.
9. Huang ZY, Yao B, Jiang HY, et al. Changes in content of inflammatory cytokines and troponin I in peri-operative periods of coronary artery bypass grafting with or without cardiopulmonary bypass. Chin Crit Care Med, 2005, 17:168-170.
10. Casey LC. Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. Ann Thorac Surg, 1993, 56:92-96.
11. Hirai S. Systemic inflammatory response syndrome after cardiac surgery under cardiopulmonary bypass. Ann Thorac Cardiovasc Surg, 2003, 9:365-370.
12. Fujimori A, Naito H, Miyazaki T. Adsorption of complement, cytokines, and proteins by different dialysis membrane materials: evaluation by confocal laser scanning fluorescence microscopy. Artif Organs, 1998, 22:1014-1017.
13. De Vriese AS, Colardyn FA, Philippe JJ, et al. Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol, 1999, 10:846-853.
14. Dahaba AA, Elawady GA, Rehak PH, et al. Procalcitonin and proinflammatory cytokine clearance during continuous venovenous haemofiltration in septic patients. Anaesth Intensive Care, 2002, 30:269-274.
15. Varela MP, Kimmel PL, Phillips TM, et al. Biocompatibility of hemodialysis membranes: interrelations between plasma complement and cytokine levels. Blood Purif, 2001, 19:370-379.
16. Neote K, Darbonne W, Ogez J, et al. Identification of a promisacuous inflammatory peptide receptor on the surface of red blood cells. J Biol Chem, 1993, 268:12247-12249.
17. Gormley SMC, McBride WT, Armstrong MA, et al. Plasma and urine cytokine homeostasis and renal dysfunction during cardiac surgery. Anesthesiology, 2000, 93:1210-1216.
18. McBride WT, Allen S, Gormley SMC, et al. Methylprednisolone favourably alters plasma and urinary cytokine homeostasis and subclinical renal injury at cardiac surgery. Cytokine, 2004, 27:81-89.
19. Hennein HA, Ebba H, Rodriguez JL, et al. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg, 1994, 108:626-535.
20. Kawamura T, Inada K, Nara N, et al. Influence of methylprednisolone on cytokine balance during cardiac surgery. Crit Care Med, 1999, 27:545-548.
21. Wanner GA, Keel M, Steckholzer U, et al Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med, 2000, 28: 950-957.